• AZ and ICL link to research respiratory diseases pharmatimes
    December 25, 2017
    AstraZeneca and Imperial College London have announced plans to work together on investigating the scientific mechanisms and underlying drivers of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).
PharmaSources Customer Service